@article{32f370ba3c5f4ed4a82cf6ef467c9377,
title = "Quality assurance of spirometry in a population-based study-predictors of good outcome in spirometry testing",
author = "Tan, {Wan C.} and Jean Bourbeau and Denis O'donnell and Shawn Aaron and Francois Maltais and Darcy Marciniuk and Paul Hernandez and Robert Cowie and Kenneth Chapman and {Sonia Buist}, A. and Don Sin and {Mark Fitzgerald}, J.",
note = "Funding Information: In the past 5 years, Dr. Darcy Marciniuk received funding support to attend a symposium from AstraZen-eca, Boehringer Ingelheim, GlaxoSmithKline, Nycomed, and Pfizer; for speaking from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Nycomed, and Pfizer; for consulting from AstraZeneca, Canadian Agency for Drugs and Technology in Health, GlaxoSmithKline, Health Canada, Health Quality Council, Novartis, Nycomed, Pfizer, Public Health Agency of Canada, Saskatchewan Medical Association and the Saskatoon Health Region; for research (directed to the University of Saskatchewan) from AstraZeneca, Boehringer Ingelheim, Canadian Agency for Drugs and Technology in Health, Canadian Institute of Health Research, Dal-housie University, Forest Research, GlaxoSmithKline, Lung Association of Saskatchewan, McGill University, Nycomed, Saskatchewan Health Research Foundation, Saskatchewan Ministry of Health, Schering, Pfizer, and the University of Alberta; and for organizing education from the American College of Chest Physicians, Boehringer Ingelheim, Canadian Thoracic Society, Merck, Nycomed, and the University of Saskatchewan. Dr. Marciniuk is an employee of the University of Saskatchewan. Funding Information: Denis O{\textquoteright}Donnell has served on advisory boards for Boehringer Ingelheim, Pfizer, GSK, Novartis, and Nycomed; has received lecture fees from Boehringer Ingelheim, Astra Zeneca, Pfizer, and GSK; and has received industry-sponsored grants from Boehringer Ingelheim, GSK, and Merck Frosst Canada and from Novartis and Pfizer. Funding Information: Wan C. Tan has received funding for the operations of the Canadian Obstructive Lung Disease epidemiological study from unrestricted educational grants from Glaxo-SmithKline, Pfizer, Boehringer Ingelheim, AstraZeneca.",
year = "2014",
month = apr,
doi = "10.3109/15412555.2013.822857",
language = "English",
volume = "11",
pages = "143--151",
journal = "COPD: Journal of Chronic Obstructive Pulmonary Disease",
issn = "1541-2555",
publisher = "Informa Healthcare",
number = "2",
}